Companies Accendra Health
Accendra Health (OMI): executive pay, fiscal 2025
Free brief. Every figure links to the company’s own filing.
Velarion Intel: free for 3 days, no card →Email me Accendra Health’s executive pay brief as a PDF
You get it on this page the moment you ask, and a copy by email. Every figure is cited to its filing.
After the PDF, up to three short notes on the deeper reports for this company. Reply “unsubscribe” to any of them, any time.
CEO pay, last three years
- $8,389,910FY2023
- $10,737,905FY2024
- $11,157,809FY2025
CEO total pay was $11,157,809 in fiscal 2025, up from $10,737,905 in fiscal 2024.
FY2025: salary $1,150,000 · bonus $0 · stock awards $9,560,140 · option awards $0
Executives and directors
Frequently asked questions
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Full detail
Every table from the filing. Open any section.
Summary compensation table
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Edward Pesicka | $1,150,000 | $0 | $9,560,140 | $0 | $345,000 | $0 | $102,669 | $11,157,809 |
| President & Chief Executive Officer | ||||||||
| Andrew Long | 691,866 | 0 | 2,879,578 | 0 | 0 | 0 | 15,736 | 3,587,180 |
| Executive Vice President, Chief Executive Officer, Products & Healthcare Services | ||||||||
| Perry Bernocchi | 644,417 | 0 | 2,649,205 | 0 | 119,070 | 0 | 10,913 | 3,423,605 |
| Executive Vice President, Chief Operating Officer | ||||||||
| Jonathan Leon | 572,885 | 300,000 | 2,073,293 | 0 | 0 | 0 | 16,528 | 2,962,706 |
| Executive Vice President & Chief Financial Officer | ||||||||
| Heath Galloway | 513,731 | 265,000 | 1,497,382 | 0 | 0 | 0 | 18,493 | 2,294,606 |
| Executive Vice President, General Counsel & Corporate Secretary | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
Three-year trend — total compensation per named executive
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Edward Pesicka | $11,157,809 | $10,737,905 | $8,389,910 | ↑ +419,904 |
| Andrew Long | 3,587,180 | 4,026,436 | 4,724,545 | ↓ −439,256 |
| Perry Bernocchi | 3,423,605 | 3,652,733 | 3,190,882 | ↓ −229,128 |
| Jonathan Leon | 2,962,706 | 2,290,912 | — | ↑ +671,794 |
| Heath Galloway | 2,294,606 | 2,171,222 | — | ↑ +123,384 |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
Incentive-plan design — the Compensation Discussion & Analysis
Our executive compensation programs are designed to reflect a pay-for-performance philosophy that aligns with the business’s strategy and goals, both short and long-term, and pays for sustained performance, profitable growth, and achievement of results. We generally target the 50th percentile of our peer group and the relevant market as a reference point for positioning target total compensation for our executives, with the ability to earn above or below the 50th percentile based on Company and/or individual performance.
| CEO STI target (% of salary) | — |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Frederic W. Cook & Co., Inc. (FW Cook) |
| Clawback policy | true |
| Anti-hedging | true |
| Anti-pledging | true |
Equity grants and outstanding awards
No plan-based awards are on file for this fiscal year.
Outstanding equity awards at fiscal year-end 2025
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Heath Galloway | RSU | 3,207 | — | $8,980 |
| Jonathan Leon | RSU | 5,879 | — | 16,461 |
| Heath Galloway | RSU | 6,050 | — | 16,940 |
| Jonathan Leon | PSU | 7,306 | — | 20,457 |
| Jonathan Leon | RSU | 11,421 | — | 31,979 |
| Heath Galloway | RSU | 16,316 | — | 45,685 |
| Jonathan Leon | PSU | 17,811 | — | 49,871 |
| Jonathan Leon | RSU | 19,202 | — | 53,766 |
| Perry Bernocchi | RSU | 21,374 | — | 59,847 |
| Heath Galloway | PSU | 24,351 | — | 68,183 |
| Jonathan Leon | RSU | 28,766 | — | 80,545 |
| Perry Bernocchi | RSU | 29,911 | — | 83,751 |
| Andrew Long | RSU | 33,990 | — | 95,172 |
| Perry Bernocchi | PSU | 44,643 | — | 125,000 |
| Andrew Long | RSU | 45,953 | — | 128,668 |
| Andrew Long | PSU | 50,731 | — | 142,047 |
| Edward Pesicka | RSU | 58,777 | — | 164,576 |
| Perry Bernocchi | PSU | 64,767 | — | 181,348 |
| Heath Galloway | RSU | 69,743 | — | 195,280 |
| Heath Galloway | PSU | 69,743 | — | 195,280 |
| Andrew Long | PSU | 74,482 | — | 208,550 |
| Jonathan Leon | RSU | 96,567 | — | 270,388 |
| Jonathan Leon | PSU | 96,567 | — | 270,388 |
| Edward Pesicka | RSU | 99,250 | — | 277,900 |
| Perry Bernocchi | RSU | 123,391 | — | 345,495 |
| Perry Bernocchi | PSU | 123,391 | — | 345,495 |
| Andrew Long | RSU | 134,121 | — | 375,539 |
| Andrew Long | PSU | 134,121 | — | 375,539 |
| Edward Pesicka | PSU | 148,134 | — | 414,775 |
| Edward Pesicka | PSU | 178,109 | — | 498,705 |
| Edward Pesicka | RSU | 445,279 | — | 1,246,781 |
| Edward Pesicka | PSU | 445,279 | — | 1,246,781 |
Director compensation
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Robert J. HenkelIndependent | $131,250 | $205,000 | — | — | — | $336,250 |
| Rita F. Johnson-MillsIndependent · Governance Nominating | 125,000 | 205,000 | — | — | — | 330,000 |
| Carissa L. RollinsIndependent · Audit | 125,000 | 205,000 | — | — | — | 330,000 |
Board fee structure and ownership guideline
| Annual cash retainer | $125,000 |
|---|---|
| Annual equity retainer | $205,000 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 30,000 / 25,000 / 25,000 |
| Stock ownership guideline | — |
Total cost of the board
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $381,250 |
| Equity awards (grant-date value) | $615,000 |
| All other compensation | $0 |
| Total cost of the board | $996,250 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Peer group, and who names Accendra Health as a peer
Companies that benchmark against OMI
12 companies name OMI as a compensation peer
- AdaptHealth Corp.AHCOFY2025
- APPLIED INDUSTRIAL TECHNOLOGIES INCAITFY2026
- CARDINAL HEALTH INCCAHFY2026
- COMMUNITY HEALTH SYSTEMS INCCYHFY2025
- HENRY SCHEIN INCHSICFY2025
- Option Care Health, Inc.OPCHFY2025
- PATTERSON COMPANIES, INC.PDCOFY2024
- Premier, Inc.PINCFY2024
- QUEST DIAGNOSTICS INCDGXFY2025
- SpartanNash CoSPTNFY2024
Each company listed discloses OMI in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named OMI in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
Chief executive pay against the peer group
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company’s own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Accendra Health | 2025 | Edward Pesicka | $1,150,000 | $9,560,140 | $0 | $345,000 | $11,157,809 |
Each peer’s compensation is from its most recently filed proxy; fiscal years differ by company. Each peer’s figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Say-on-pay history and pay ratio
No say-on-pay vote is on file for this company.
Insider trades since the proxy
No insider equity transactions reported since the proxy statement.
Sources (11 citations)
Each figure is listed with the filing it comes from, where it appears in that filing, and the value as printed. Any figure can be independently confirmed against the source.
- Section 01, Edward Pesicka. DEF 14A, filed 2026-04-02. Section “2025 Summary Compensation Table” · page 46. As printed: 11,157,809. View filing ↗
- Section 01, Andrew Long. DEF 14A, filed 2026-04-02. Section “2025 Summary Compensation Table” · page 46. As printed: 3,587,180. View filing ↗
- Section 01, Perry Bernocchi. DEF 14A, filed 2026-04-02. Section “2025 Summary Compensation Table” · page 46. As printed: 3,423,605. View filing ↗
- Section 01, Jonathan Leon. DEF 14A, filed 2026-04-02. Section “2025 Summary Compensation Table” · page 46. As printed: 2,962,706. View filing ↗
- Section 01, Heath Galloway. DEF 14A, filed 2026-04-02. Section “2025 Summary Compensation Table” · page 46. As printed: 2,294,606. View filing ↗
- Section 08, Robert J. Henkel. DEF 14A, filed 2026-04-02. Section “Director Compensation”. As printed: 336,250. View filing ↗
- Section 08, Rita F. Johnson-Mills. DEF 14A, filed 2026-04-02. Section “Director Compensation”. As printed: 330,000. View filing ↗
- Section 08, Carissa L. Rollins. DEF 14A, filed 2026-04-02. Section “Director Compensation”. As printed: 330,000. View filing ↗
- Section 01 trend, Δ column (computed). Computed. Δ = current-FY total − prior-FY total per named officer.
- Section 09b board cost (computed). Computed. Cash 381,250 + equity 615,000 + all other 0 = 996,250, summed across the director compensation table rows.
- Accendra Health (subject), Section 10b CEO total. DEF 14A, filed 2026-04-02. CEO total compensation as printed in Accendra Health's own proxy. As printed: 11,157,809. View filing ↗